SavedAdd your journal

Journals / The Anatolian Journal of Cardiology / 2016 / Cilt: 16 - Sayı: 5

Association between platelet to lymphocyte ratio and saphenous vein graft disease in patients with stable angina pectoris

Harun KUNDİ
Ahmet BALUN
Hülya ÇİÇEKÇİOĞLU
Mustafa ÇETİN
EMRULLAH KIZILTUNÇ
Pages
349–353
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This study suggests that PLR can be used as a marker of SVGD because it is an easily available and inexpensive test.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: In this study, we aimed to investigate the relation of platelet to lymphocyte ratio (PLR) in saphenous vein graft disease (SVGD) in patients with stable angina pectoris after coronary artery bypass graft surgery.Methods: A total of 455 patients were included in the study.
📊
Key Findings & Data:There were 210 patients with SVGD and 245 patients without SVGD.
💡
Conclusion & Impact:This study suggests that PLR can be used as a marker of SVGD because it is an easily available and inexpensive test.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: In this study, we aimed to investigate the relation of platelet to lymphocyte ratio (PLR) in saphenous vein graft disease (SVGD) in patients with stable angina pectoris after coronary artery bypass graft surgery.Methods: A total of 455 patients were included in the study. There were 210 patients with SVGD and 245 patients without SVGD. The effects of different variables on SVGD were computed in logistic regression analysis.Results: The platelet count, lymphocyte count, PLR, high-density lipoprotein (HDL), Na, and ALT were significantly associated with SVGD. In multivariate regression analysis, HDL and PLR were found to be significantly associated with SVGD.Conclusion: To the best of our knowledge, this is the first study showing the significant association of PLR with SVGD. This study suggests that PLR can be used as a marker of SVGD because it is an easily available and inexpensive test.

🔖

Cite This Article

KUNDİ, H., BALUN, A., ÇİÇEKÇİOĞLU, H., ÇETİN, M., KIZILTUNÇ, E. (2016). Association between platelet to lymphocyte ratio and saphenous vein graft disease in patients with stable angina pectoris. The Anatolian Journal of Cardiology, Cilt: 16 - Sayı: 5, 349–353. https://ajindex.com/articles/365509

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Goldman S, Zadina K, Moritz T, Ovitt T, Sethi G, Copeland JG, et al. Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery: results from a Department of Veterans Affairs Cooperative Study. J Am Coll Cardiol 2004; 44: 2149-56
  2. Von Hundelshausen P, Schmitt MM. Platelets and their chemokines in atherosclerosis-clinical applications. Front Physiol 2014; 5: 294
  3. Tavil Y, Şen N, Yazıcı HU, Hızal F, Açıkgöz SK, Turfan M, et al. Relationship between elevated platelet volume and saphenous vein graft disease. Clin Invest Med 2010; 33: E161-7
  4. Ege M, Güray U, Güray Y, Açıkgöz S, Demirkan B. Platelet distribution width and saphenous vein disease in patients after CABG. Herz 2013; 38: 197-201
  5. Akpınar I, Sayın MR, Gürsoy YC, Karabağ T, Küçük E, Büyükuysal MC, et al. Plateletcrit. A platelet marker associated with saphenous vein graft disease. Herz 2014; 39: 142-8
  6. Horne BD, Anderson JL, John JM, Weaver A, Bair TL, Jensen KR, et al; Intermountain Heart Collaborative Study Group. Which white blood cell subtypes predict increased cardiovascular risk? J Am Coll Cardiol 2005; 45: 1638-43
  7. Bikdeli B, Hassantash SA, Pourabdollah M, Kalantarian S, Sadeghian M, Afshar H, et al. Histopathologic insight into saphenous vein bypass graft disease. Cardiology 2012; 123: 208-15
  8. Açar G, Kalkan ME, Avcı A, Alizade E, Tabakcı MM, Toprak C, et al. The relation of platelet-lymphocyte ratio and coronary collateral circulation in patients with stable angina pectoris and chronic total occlusion. Clin Appl Thromb Hemost 2015; 21: 462-8
  9. Azab B, Shah N, Akerman M, McGinn Jr JT. Value of platelet/lymphocyte ratio as a predictor of all-cause mortality after non-ST-elevation myocardial infarction. J Thromb Thrombolysis 2012; 34: 326-34
  10. Temiz A, Gazi E, Güngör Ö, Barutçu A, Altun B, Bekler A, et al. Platelet/lymphocyte ratio and risk of in-hospital mortality in patients with ST-elevated myocardial infarction. Med Sci Monit 2014; 20: 660-5
  11. Oylumlu M, Yıldız A, Oylumlu M, Yüksel M, Polat N, Bilik MZ, et al. Platelet-to-lymphocyte ratio is a predictor of in-hospital mortality patients with acute coronary syndrome. Anatol J Cardiol 2015; 15: 277-83
  12. Yüksel M, Yıldız A, Oylumlu M, Akyüz A, Aydın M, Kaya H, et al. The association between platelet/lymphocyte ratio and coronary artery disease severity. Anatol J Cardiol 2014 Jul 11
  13. Yıldız A, Yüksel M, Oylumlu M, Polat N, Akyüz A, Acet H, et al. The util